Growing Multi-Site Sleep Disorder Clinic with $3M Revenue and $630K Adjusted EBITDA

This listing presents a well-established, multi-site sleep disorder clinic operating in the Pacific Northwest, founded in 2002. The business offers a comprehensive suite of services including in-lab sleep studies (Polysomnography), Home Sleep Testing (HST), Pediatric Polysomnography, Multiple Sleep Latency Tests (MSLT), Multiple Wakefulness Tests (MWT), CPAP Therapy, SleepN Follow Up & Remote Monitoring, Telemedicine Consultation, and sales/service of sleep DME equipment. All four locations are accredited by the American Academy of Sleep Medicine. The clinic serves both children and adults, partners with approximately 200 physician-providers, and conducts nearly 2,000 sleep studies annually. Financials show strong growth, with projected 2022 gross revenues of $3 million and an adjusted EBITDA of $630,000. The company benefits from a recognized brand, excellent reputation, and a high barrier to entry. All staff are expected to remain post-acquisition, and the CEO is willing to stay for a transition period. The seller is seeking a strategic investor to leverage the existing platform for further expansion, with potential for earnout options.